Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.
Himanshu Malani
Advertisement
Himanshu Malani is a graduate student at the Indian Institute of Technology, Delhi.
Articles by Himanshu Malani
Advertisement
Latest Updated Articles
Reimagining Affordable BiosimilarsPublished: October 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
